Black Rock Inc. Exelixis, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 33,502,228 shares of EXEL stock, worth $1.1 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares

33,502,228

Previous 34,882,633 3.96%

Holding current value

$1.1 Billion

Previous $828 Million 9.06%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$20.34 - $23.73 $28.1 Million - $32.8 Million	-1,380,405 Reduced 3.96%	33,502,228 $753 Million
Q1 2024 May 10, 2024	SELL	$20.17 - $23.93 $22.8 Million - $27.1 Million	-1,131,799 Reduced 3.14%	34,882,633 $828 Million
Q4 2023 Feb 13, 2024	SELL	$19.25 - $24.13 $19.5 Million - $24.4 Million	-1,010,897 Reduced 2.73%	36,014,432 $864 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $31.2 Million - $37.2 Million	1,638,006 Added 4.63%	37,025,329 $809 Million
Q2 2023 Aug 11, 2023	SELL	$18.17 - $20.48 $15 Million - $16.9 Million	-826,851 Reduced 2.28%	35,387,323 $676 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $27.4 Million - $32.7 Million	1,683,880 Added 4.88%	36,214,174 $703 Million
Q4 2022 Feb 13, 2023	BUY	$14.96 - $17.39 $9.5 Million - $11 Million	634,974 Added 1.87%	34,530,294 $554 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $5.31 Million - $7.54 Million	338,589 Added 1.01%	33,895,320 $531 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $11.7 Million - $15.6 Million	672,170 Added 2.04%	33,556,731 $699 Million
Q1 2022 May 12, 2022	BUY	$17.03 - $22.67 $10.3 Million - $13.8 Million	607,183 Added 1.88%	32,884,561 $745 Million
Q4 2021 Feb 10, 2022	BUY	$15.84 - $21.88 $5.87 Million - $8.1 Million	370,331 Added 1.16%	32,277,378 $590 Million
Q3 2021 Nov 09, 2021	BUY	$16.3 - $21.14 $9.98 Million - $12.9 Million	612,104 Added 1.96%	31,907,047 $675 Million
Q2 2021 Aug 11, 2021	BUY	$17.95 - $25.56 $562 Million - $800 Million	31,294,943 New	31,294,943 $570 Million

Others Institutions Holding EXEL

# of Institutions

518

Shares Held

243M

Call Options Held

2.84M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account